Apimeds Pharmaceuticals US, Inc (APUS) Financials

$2.08

$0 (0%)
Last update: 10:19 AM EST
Day's range
$2.06
Day's range
$2.13

APUS Income statement / Annual

Last year (2024), Apimeds Pharmaceuticals US, Inc's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Apimeds Pharmaceuticals US, Inc's net income was -$1.39 M. See Apimeds Pharmaceuticals US, Inc,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $0.00 $98.54 K $368.00 K $489.94 K
General & Administrative Expenses $1.28 M $648.89 K $271.53 K $529.56 K
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $1.28 M $648.89 K $271.53 K $529.56 K
Other Expenses $0.00 $0.00 $0.00 $0.00
Operating Expenses $1.28 M $747.44 K $639.53 K $1.02 M
Cost And Expenses $1.28 M $747.44 K $639.53 K $1.02 M
Interest Income $2.82 K $7.81 K $0.00 $0.00
Interest Expense $117.72 K $38.07 K $29.14 K $6.74 K
Depreciation & Amortization $0.00 $0.00 $0.00 $0.00
EBITDA -$1.27 M -$739.63 K -$639.53 K -$1.02 M
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net -$114.90 K -$30.26 K -$29.14 K -$6.74 K
Income Before Tax -$1.39 M -$777.69 K -$668.67 K -$1.03 M
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Net Income -$1.39 M -$777.69 K -$668.67 K -$1.03 M
Net Income Ratio 0 0 0 0
EPS -0.12 -0.0675 -0.058 -0.089
EPS Diluted -0.11 -0.0613 -0.0527 -0.0808
Weighted Average Shares Out $11.53 M $11.53 M $11.53 M $11.53 M
Weighted Average Shares Out Diluted $12.69 M $12.69 M $12.69 M $12.69 M
Link